Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes

Journal of Clinical Investigation

Volumn 113, Issue 8, 2004, Pages 1218-1224

  Panoutsakopoulou, Vily ^a,b,c   Huster, Katharina M ^a,b,d   McCarty, Nami ^a,b   Feinberg, Evan ^a   Wang, Rijian ^a,b   Wucherpfennig, Kai W ^a,b   Cantor, Harvey ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Foundation for Biomedical Research   (Greece)

^d I Med Microb Infect/Epid Dis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA E ANTIGEN; PEPTIDE DERIVATIVE; PROTEIN QA 1; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VACCINATION;

EID: 2142754523     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20772     Document Type: Article

References (47)

1. Cohen, I.R. 1992. The cognitive principle challenges clonal selection. Immunol. Today. 13:441-446.
2. Ota, K., et al. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
3. Holoshitz, J., Naparstek, Y., Ben-Nun, A., and Cohen, I.R. 1983. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219:56-58.
4. Cantor, H. 2000. T-cell receptor crossreactivity and autoimmune disease. Adv. Immunol. 75:209-233.
5. Lider, O., Reshef, T., Beraud, E., Ben Nun, A., and Cohen, I.R. 1988. Anti-idiotypic network induced by T cell vaccination against experimental auroimmune encephalomyelitis. Science 239:181-183.
6. Ben-Nun, A., Wekerle, H., and Cohen, I.R. 1981. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature. 292:60-61.
7. Formby, B., and Shao, T. 1993. T cell vaccination against autoimmune diabetes in nonobese diabetic mice. Ann. Clin. Lab. Sci. 23:137-147.
8. Correale, J., et al. 2000. T cell vaccination in secondary progressive multiple sclerosis. J. Neuroimmunol. 107:130-139.
9. Medaet, R., Stinissen, P., Truyen, L., Raus, J., and Zhang, J. 1995. Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis. Lancet. 346:807-808.
10. Noble, A., Zhao, Z.-S., and Cantor, H. 1998. Suppression of immune responses by CD8 cells: 11. Qa-1 on activated B-cells stimulates CD8 cell suppression of Th2-dependent antibody responses. J. Immunol. 160:566-571.
11. Jiang, H., et al. 1995. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing Vβ8 TCR: role of the Qa-1 molecule. Immunity. 2:185-194.
12. Jiang, H., Braunstein, N.S., Yu, B., Winchester, R., and Chess, L. 2001. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc. Natl. Acad. Sci. U. S. A. 98:6301-6306.
13. Zhang, J., Medaer, R., Stinissen, P., Hafler, D., and Raus, J. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science. 261:1451-1454.
14. Zhang, J., Vandevyver, C., Stinissen, P., and Kaus, J. 1995. In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J. Immunol 185:5868-5877.
15. Zhang, Y.C.Q., Hong, J., Rivera, V.M., Killian, J., and Zhang, J.Z. 2000. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J. Immunol. 164:4011-4017.
16. Gaur, A., Haspel, R., Mayer, J.P., and Fathman, C.G. 1993. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science, 289:91-94.
17. Jiang, H., et al. 1998. T cell vaccination induces TCR Vβ specific, Qa-1 restricted regulatory CD8+ T cells. Proc. Natl. Acad. Sci. U. S. A. 95:4533-4537.
18. Dawson, C., and Togni, G. 1976. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv. Ophthalmol. 21:11-29.
19. Avery, A.C., et al. 1995. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 376:431-434.
20. Zhao, Z.-S., Granucci, F., Yeh, L., Schaffer, P.A., and Cantor, H. 1998. Molecular mimicry by herpes simplex virus-1: autoimmune disease after viral infection. Science. 279:1344-1347.
21. Panoutsakopoulou, V., et al. 2001. Analysis of the relationship between viral infection and autoimmune disease. Immunity. 15:137-147.
22. Chen, J., et al. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5:647-656.
23. Friedman, S., Sillcocks, D., and Cantor, H. 1987. Alloreactivity of an OVA-specific T-cell clone. 1. Stimulation by class II MHC and novel non-MHC B-cell determinants. Immunogenetics. 26:193-203.
24. Wang, R., Ramaswamy, S., Hu, D., and Cantor, H. 2001. Definition of a novel binding site on CD8 cells for a conserved region of the MHC class Ib molecule Qa-1 that regulates IFN-gamma expression. Eur. J. Immunol. 31:87-93.
25. Hoglund, P. et al. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331-339.
26. Kumar, V., and Setcarz, E.E. 1993. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909-916.
27. Kumar, V., Stellrecht, K., and Sercarz, E. 1996. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 184:1609-1617.
28. Holoshitz, J., Frenkel, A., Ben-Nun, A., and Cohen, I.R. 1983. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific. J. Immunol. 131:2810-2813.
29. Lohse, A.W., Mor, F., Karin, N., and Cohen, I.R. 1989. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science. 244:820-822.
30. Lo, W.F., Ong, H., Metcalf, E.S., and Soloski, M.J. 1999. T cell responses to gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:5398-5406.
31. Kurepa, Z., Hasemann, C.A., and Forman, J. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188:973-978.
32. Davies, A., et al. 2003. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm. J. Immunol. 170:5027-5033.
33. Gays, F., et al. 2001. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis. J. Immunol. 166:1601-1610.
34. Brooks, A.G., et al. 1999. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162:305-313.
35. Sun, D., Qin, Y., Chluba, J., Epplen, J.T., and Wekerle, H. 1998. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interaction. Nature. 332:843-845.
36. Stanton, T.H., et al. 1978. The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sers, mitogen responses and immune functions. J. Exp. Med. 148:963-973.
37. Cantor, H., et al 1978. 2. Immunoregulatory circuits among T-cell subsets-2. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J. Exp. Med. 147:1116-1125.
38. Cantor, H., et al. 1978. Immunoregulatory circuits among T cell sets. Identification of a subpopulation of T-helper cells that induces feedback inhibition. J. Exp. Med. 148:871-877.
39. Eardley, D.D., et al. 1978. Immunoregulatory circuits among T cell sets. I. T helper cells induce T-cell sets to exert feedback inhibition. J. Exp. Med. 147:1106-1115.
40. Naparstek, Y., et al. 1983. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur. J. Immunol. 13:418-423.
41. Shevach, E.M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18:423-449.
42. Jiang, H., et al. 2003. Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc. Natl. Acad Sci. U. S. A. 100:8378-8383.
43. Jiang, H., and Chess, L. 2004. An integrated model of immunoregulation mediated by regulatory T cell subsets. Adv. Immunol. In press.
44. Sakaguchi, S., et al. 2001. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32.
45. von Herrath, M.G. Dockter, J., and Oldstone, M.B. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity. 1:231-242.
46. Sullivan, B.A., Kraj, P., Weber, D.A., Ignatowicz, L., and Jensen, P.E. 2002. Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity. 17:95-105.
47. Tompkins, S.M., Kraft, J.R., Dao, C.T., Soloski, M.J., and Jensen, P.E. 1998. Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class 1b gene product, Qa-1(b). J. Exp. Med. 188:961-971.